Literature DB >> 26807241

Extramedullary blast crisis as initial presentation in chronic myeloid leukemia with the e1a2 BCR-ABL1 transcript: A case report.

D I Ai1, Wei Liu2, Gary Lu3, Keyur Pravinchandra Patel3, Z I Chen4.   

Abstract

A 23-year-old woman presented with enlarged right inguinal lymph nodes. The pathological examination of the nodes revealed infiltration by myeloid sarcoma. A bone marrow smear and biopsy revealed cytogenetic abnormalities, with 46,XX,t(9;22) and chronic myeloid leukemia (CML) was diagnosed. The e1a2 BCR-ABL1 fusion transcript was detected. The patient received imatinib-based combined chemotherapy, allogeneic hematopoietic stem cell transplantation, donor lymphocyte infusions and dasatinib treatment. The patient achieved complete response and has remained leukemia-free for >48 months. To the best of our knowledge, this is the first case report of CML with the e1a2 BCR-ABL1 transcript, with extramedullary blast crisis as the initial presentation. The aim of the present study was to discuss this special case with reference to the literature.

Entities:  

Keywords:  bone marrow transplant; chronic myeloid leukemia; e1a2 transcript; extramedullary blast crisis; targeted therapy

Year:  2015        PMID: 26807241      PMCID: PMC4665541          DOI: 10.3892/mco.2015.641

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  8 in total

1.  "Isolated" peritoneal granulocytic sarcoma with molecular and chromosomal bone marrow involvement.

Authors:  Atto Billio; Graziano Pianezze; Barbara Amato; Pietro Fabris
Journal:  Haematologica       Date:  2002-01       Impact factor: 9.941

2.  Clinical activity of ponatinib in patients with chronic myeloid leukemia in chronic phase with e1a2 transcripts.

Authors:  Preetesh Jain; Carlos Guillermo Romo; Hanna J Khoury; Hagop Kantarjian; Jorge Cortes
Journal:  Haematologica       Date:  2013-11       Impact factor: 9.941

3.  Chronic myeloid leukemia with p190BCR-ABL: prevalence, morphology, tyrosine kinase inhibitor response, and kinase domain mutation analysis.

Authors:  Animesh Pardanani; Ayalew Tefferi; Mark R Litzow; Clive Zent; William J Hogan; Rebecca F McClure; David Viswanatha
Journal:  Blood       Date:  2009-10-15       Impact factor: 22.113

4.  Comprehensive analysis of BCR-ABL transcript types in Korean CML patients using a newly developed multiplex RT-PCR.

Authors:  Hyun-Gyung Goh; Ji-Yeon Hwang; Soo-Hyun Kim; Young-Hoon Lee; Yoo-Li Kim; Dong-Wook Kim
Journal:  Transl Res       Date:  2006-11       Impact factor: 7.012

5.  Chronic myeloid leukemia (CML) with P190 BCR-ABL: analysis of characteristics, outcomes, and prognostic significance.

Authors:  Dushyant Verma; Hagop M Kantarjian; Dan Jones; Rajyalakshmi Luthra; Gautam Borthakur; Srdan Verstovsek; Mary Beth Rios; Jorge Cortes
Journal:  Blood       Date:  2009-06-16       Impact factor: 22.113

6.  P190BCR-ABL chronic myeloid leukaemia: the missing link with chronic myelomonocytic leukaemia?

Authors:  J V Melo; H Myint; D A Galton; J M Goldman
Journal:  Leukemia       Date:  1994-01       Impact factor: 11.528

7.  BCR/ABL p210, p190 and p230 fusion genes in 250 Mexican patients with chronic myeloid leukaemia (CML).

Authors:  R M Arana-Trejo; E Ruíz Sánchez; G Ignacio-Ibarra; E Báez de la Fuente; O Garces; E Gómez Morales; M Castro Granados; R Ovilla Martínez; M E Rubio-Borja; L Solís Anaya; P Herrera; J Delgado Llamas; S Kofman
Journal:  Clin Lab Haematol       Date:  2002-06

8.  Isolated duodenal myeloid sarcoma associated with the CBFβ/MYH11 fusion gene followed by acute myeloid leukemia progression: A case report and literature review.

Authors:  Bo Huang; Peng You; Ping Zhu; Zunguo DU; Beiqian Wu; Xiaoping Xu; Zi Chen
Journal:  Oncol Lett       Date:  2014-07-04       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.